“Serious adverse reactions could occur in patients with a sulfite allergy who are exposed to hydromorphone containing sulfites,” the company said in its recall notice.
The affected product is 0.5 mg/mL hydromorphone HCl in 0.9 percent sodium chloride 1 mL in 3 mL BD syringe.
PharMEDium said it has notified its customers and arranged replacement orders.
More articles on pharmacy:
Walmart cutting some pharmacy jobs
UPMC acquires community pharmacy in Pittsburgh
Oklahoma judge approves Teva’s $85M opioid settlement
